We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stent Makers on the Move Following FDA Vote
Stent Makers on the Move Following FDA Vote
December 3, 2007
Drug stocks climbed into positive territory Friday as shares of makers of coronary stents reacted the day after a panel of the Food and Drug Administration voted to recommend approval of Abbott Laboratories’ and Boston Scientific’s new drug-coated stent. MarketWatch
